HEARTFLOW ($HTFL) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of -$0.07 per share, beating estimates of -$0.14 by $0.07. The company also reported revenue of $64,080,000, beating estimates of $57,775,350 by $6,304,650.
Stock price change since market close: +15.99%
You can see Quiver Quantitative's $HTFL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HEARTFLOW Insider Trading Activity
HEARTFLOW insiders have traded $HTFL stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $HTFL stock by insiders over the last 6 months:
- CAPITAL LIFE SCIENCES INVESTORS, LLC BAIN has made 0 purchases and 4 sales selling 2,000,000 shares for an estimated $58,898,336.
- CAMPBELL ROGERS (Chief Medical Officer) has made 0 purchases and 5 sales selling 212,657 shares for an estimated $5,341,991.
- JOHN C.M. FARQUHAR (Chief Executive Officer) has made 0 purchases and 8 sales selling 174,272 shares for an estimated $5,063,216.
- JULIE A CULLIVAN sold 9,122 shares for an estimated $228,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
HEARTFLOW Hedge Fund Activity
We have seen 129 institutional investors add shares of HEARTFLOW stock to their portfolio, and 57 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- XXEC, INC. added 76,992,164 shares (+27627.3%) to their portfolio in Q2 2026, for an estimated $2,258,950,091
- WELLINGTON MANAGEMENT GROUP LLP added 6,088,213 shares (+103.3%) to their portfolio in Q1 2026, for an estimated $148,126,222
- BLACKROCK, INC. added 3,735,163 shares (+255.4%) to their portfolio in Q2 2026, for an estimated $109,589,682
- BAILLIE GIFFORD & CO removed 3,005,998 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $88,195,981
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC removed 2,000,000 shares (-16.1%) from their portfolio in Q1 2026, for an estimated $48,660,000
- SCHUSTERMAN INTERESTS, LLC removed 1,679,535 shares (-86.6%) from their portfolio in Q1 2026, for an estimated $40,863,086
- BAMCO INC /NY/ added 1,523,654 shares (+66.1%) to their portfolio in Q1 2026, for an estimated $37,070,501
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
HEARTFLOW Analyst Ratings
Wall Street analysts have issued reports on $HTFL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 05/04/2026
To track analyst ratings and price targets for HEARTFLOW, check out Quiver Quantitative's $HTFL forecast page.
HEARTFLOW Price Targets
Multiple analysts have issued price targets for $HTFL recently. We have seen 4 analysts offer price targets for $HTFL in the last 6 months, with a median target of $37.0.
Here are some recent targets:
- Gene Mannheimer from Freedom Capital Markets set a target price of $37.0 on 07/01/2026
- Larry Biegelsen from Wells Fargo set a target price of $37.0 on 05/15/2026
- William Plovanic from Canaccord Genuity set a target price of $37.0 on 05/15/2026
- Robbie Marcus from JP Morgan set a target price of $35.0 on 03/19/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
